Search

Displaying results 8911 - 8920 of 10000 in total
  1. Drug

    Vorsetuzumab mafodotin

    go.drugbank.com/drugs/DB15352
    Investigational

    Vorsetuzumab mafodotin is under investigation in clinical trial NCT01677390 (A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma).

  2. Drug

    ASF-1075

    go.drugbank.com/drugs/DB05727
    Experimental

  3. Drug

    EMD-1201081

    go.drugbank.com/drugs/DB06181
    Investigational

    Categories: Toll-Like Receptor 9, agonists
  4. Drug

    Repifermin

    go.drugbank.com/drugs/DB06434
    Experimental

  5. Drug

    Edifoligide

    go.drugbank.com/drugs/DB06556
    Investigational

  6. Drug

    Regrelor

    go.drugbank.com/drugs/DB05553
    Investigational

    Categories: Purinergic P2 Receptor Antagonists
  7. Drug

    PRX-08066

    go.drugbank.com/drugs/DB05607
    Investigational

    Categories: Serotonin Receptor Antagonists, Serotonin 5-HT2 Receptor Antagonists
  8. Drug

    Cintirorgon

    go.drugbank.com/drugs/DB20916
    Investigational

    Cintirorgon is a small molecule drug. Cintirorgon is under investigation in clinical trial NCT02929862 (Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer).

  9. Drug

    NBF-006

    go.drugbank.com/drugs/DB21770
    Investigational

    NBF-006 is under investigation in clinical trial NCT03819387 (A Study of NBF-006 in Non-small Cell Lung, Pancreatic, or Colorectal Cancer). … This drug is a proprietary siRNA-based lyophilized lipid nanoparticle (LNP).[A273775, L52905]

  10. Drug

    HE-2200

    go.drugbank.com/drugs/DB06257
    Experimental